ArticleThe Canadian journal of hospital pharmacy2022

Effectiveness and Safety of Palbociclib plus Endocrine Therapy in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Real-World Results.

Cristina Fernández-Cuerva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.